NextGen Healthcare Chosen to Improve Patient Experience and Efficiency for Advanced Heart Group

NextGen Healthcare has partnered with Advanced Heart Group (AHG) based in Illinois to optimize practice operations using NextGen® Enterprise EHR and NextGen® Enterprise PM solutions. The implementation of NextGen® PXP Portal aims to enhance patient engagement by offering secure access…

Read MoreNextGen Healthcare Chosen to Improve Patient Experience and Efficiency for Advanced Heart Group

Samsara Vision Announces First SING IMT® Patient in China, Expedites Global Launch

Samsara Vision, a company dedicated to restoring vision and independence to patients suffering from late-stage age-related macular degeneration (AMD) through advanced visual prosthetic devices, has successfully completed its first SING IMT® (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. The…

Read MoreSamsara Vision Announces First SING IMT® Patient in China, Expedites Global Launch

Healthcare Realty Trust’s Sixth Corporate Responsibility Report Released

Healthcare Realty Trust Incorporated (NYSE: HR) has released its sixth annual Corporate Responsibility Report, highlighting its environmental, social, and governance (ESG) initiatives and achievements throughout 2023. The report details the Company’s progress towards key performance indicators, environmental metrics, and disclosures…

Read MoreHealthcare Realty Trust’s Sixth Corporate Responsibility Report Released

Opening of WellCare Welcome Room in Raleigh: Healthcare Resources and Community Support

WellCare of North Carolina (WellCare), the Medicaid subsidiary of Centene Corporation (NYSE: CNC), unveiled a new WellCare Welcome Room in Raleigh today. This facility serves as a dedicated space where members can learn about health plans, explore benefits, engage with…

Read MoreOpening of WellCare Welcome Room in Raleigh: Healthcare Resources and Community Support

Global Diabetes & Obesity Therapeutics 2024-2028: Lucrative GLP-1-based Multi-agonist Market

The “Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024-2028” report has been recently included in ResearchAndMarkets.com’s offerings. This comprehensive study aims to identify key growth opportunities driving the diabesity market in the coming years. It focuses on emerging business…

Read MoreGlobal Diabetes & Obesity Therapeutics 2024-2028: Lucrative GLP-1-based Multi-agonist Market